Additionally, Newland et al. found that the genetic ablation of ILC2 in Ldlr-/- mice accelerates atherosclerosis progression, which might be due to the loss of IL-5 and IL-13 expression by ILC2 cells28. The gene discussed is IL13; the disease is atherosclerosis.